J7321 HCPCS Level II code: Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

J7321 is the HCPCS code for “Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J7321

Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

Short description: Hyalgan supartz visco-3 dose

HCPCS · United States

Medicare details

The indicators CMS publishes with J7321 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
Type of service
Medical care
BETOS category
Other drugs
Added
Jan 1, 2008

Where J7321 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J7321Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J7321 mean?

J7321 is the HCPCS code for “Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J7321?

CMS lists J7321’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.